Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Hodgkin Disease 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1Sezary Syndrome 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Recurrence 1Osteosarcoma 1Neurofibrosarcoma 1Mycosis Fungoides 1Malignant mesenchymal tumor 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Liposarcoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leiomyosarcoma 1Immunoblastic Lymphadenopathy 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1

Interventions

Ifosfamide 30Methotrexate 27Doxorubicin 25Cyclophosphamide 24Cisplatin 22Filgrastim 18Etoposide 17Gemcitabine 16Leucovorin 14Magnetic Resonance Spectroscopy 11Temozolomide 10cabozantinib 9apatinib 9Specimen Handling 9Carboplatin 9fludarabine 8X-Rays 8Nivolumab 8Neoadjuvant Therapy 8Irinotecan 8Granulocyte Colony-Stimulating Factor 8Docetaxel 8Zoledronic Acid 7Vincristine 7Sirolimus 7Radiotherapy 7Phantoms, Imaging 7Biopsy 7Topotecan 6Mesna 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Osteosarcoma × indolepropanol phosphate × Clear all
NCT00023998 2013-02-04

Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

National Cancer Institute (NCI)

Phase 2 Completed
80 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡